You have 9 free searches left this month | for more free features.

adult anaplastic ependymoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Rochester (procedure,

Active, not recruiting
  • Adult Anaplastic Astrocytoma
  • +15 more
  • biopsy
  • +7 more
  • Rochester, Minnesota
    Mayo Clinic
Apr 8, 2022

Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,

Not yet recruiting
  • Anaplastic Astrocytoma
  • +17 more
    • (no location specified)
    Jun 28, 2023

    CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)

    Recruiting
    • Central Nervous System Neoplasms
    • +22 more
    • Bethesda, Maryland
      National Institutes of Health
    Mar 1, 2022

    Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma Trial in United States (other, drug, procedure)

    Active, not recruiting
    • Anaplastic Astrocytoma
    • +6 more
    • Laboratory Biomarker Analysis
    • +4 more
    • Los Angeles, California
    • +11 more
    Jul 1, 2022

    High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))

    Recruiting
    • High Grade Glioma
    • +12 more
    • LUTATHERA® (Lutetium Lu 177 dotatate)
    • Aurora, Colorado
    • +8 more
    Jan 16, 2023

    Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients

    Recruiting
    • Medulloblastoma
    • +7 more
    • SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
    • +2 more
    • Buffalo, New York
    • +2 more
    Jul 8, 2022

    Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in United States (drug,

    Terminated
    • Adult Anaplastic Astrocytoma
    • +4 more
    • Chicago, Illinois
    • +4 more
    Feb 27, 2020

    AI R&D Tool in Adult Glioma and Other Primary Brain Tumours

    Not yet recruiting
    • Brain Tumor
    • +4 more
    • Resection
    • London, United Kingdom
      Imperial College Healthcare NHS Trust
    Sep 15, 2023

    Ependymoma, Glioblastoma, Medulloblastoma Trial in Duarte (IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR

    Recruiting
    • Ependymoma
    • +3 more
    • IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR Truncated CD19-expressing Autologous T-Lymphocytes
    • Duarte, California
      City of Hope Medical Center
    Mar 9, 2022

    Anaplastic Large Cell Lymphoma, ALK-Positive, Inflammatory Myofibroblastic Tumor, Other Solid Tumor Trial in Utrecht

    Recruiting
    • Anaplastic Large Cell Lymphoma, ALK-Positive
    • +2 more
    • Paris, France
    • +1 more
    Sep 27, 2022

    Rare CNS Tumors Outcomes &Risk

    Recruiting
    • High Grade Meningioma
    • +4 more
      • Bethesda, Maryland
        National Cancer Institute (NCI)
      Jul 6, 2022

      Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor, CNS Germ Cell Tumor Trial in Houston (drug, procedure, biological)

      Recruiting
      • Anaplastic Ependymoma
      • +14 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 17, 2022

      Usage of Brigatinib in Treatment of Adult Approved Indications

      Recruiting
      • Carcinoma, Non-Small-Cell Lung
      • Anaplastic Lymphoma Kinase
      • No Intervention
      • Busan, Korea, Republic of
        Pusan National University Hospital
      Oct 19, 2022

      Anaplastic Ependymoma, Ependymoma Trial in Boston, Houston (Linear Energy Transfer-Optimized Intensity Modulated Proton Therapy,

      Recruiting
      • Anaplastic Ependymoma
      • Ependymoma
      • Linear Energy Transfer-Optimized Intensity Modulated Proton Therapy
      • +2 more
      • Boston, Massachusetts
      • +1 more
      Jan 13, 2021

      T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)

      Not yet recruiting
      • T-Cell Non-Hodgkin Lymphoma
      • +14 more
      • WU-CART-007
      • Saint Louis, Missouri
        Washington University School of Medicine
      Jan 17, 2023

      Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma Trial in Duarte (biological,

      Completed
      • Adult Anaplastic Astrocytoma
      • +6 more
      • E. coli CD-expressing genetically modified neural stem cells
      • +4 more
      • Duarte, California
        City of Hope Medical Center
      Sep 28, 2021

      Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Miami (biological, drug, procedure)

      Completed
      • Malignant Glioma
      • +3 more
      • Dendritic Cell Vaccine
      • +3 more
      • Miami, Florida
        University of Miami
      Jul 19, 2022

      Pediatric Cancer, Hodgkin Disease, CD30-Positive DLBCL Trial in Milwaukee (anti-CD30 Bispecific Antibody-armed

      Not yet recruiting
      • Pediatric Cancer
      • +11 more
      • anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC)
      • Milwaukee, Wisconsin
        Children's Wisconsin
      Sep 14, 2022

      Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)

      Active, not recruiting
      • Brain and Central Nervous System Tumors
      • +9 more
      • DNA analysis
      • +4 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Oct 28, 2021

      Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

      Active, not recruiting
      • Adult Lymphocyte Depletion Hodgkin Lymphoma
      • +16 more
      • 6,8-bis(benzylthio)octanoic acid
      • bendamustine hydrochloride
      • Winston-Salem, North Carolina
      • +1 more
      Apr 8, 2022

      T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

      Recruiting
      • T-cell Lymphoma
      • +30 more
      • Optional Blood Sample
      • Optional Nail Sample
      • Duarte, California
      • +25 more
      Jul 28, 2023

      Peripheral T Cell Lymphoma, PTCL, Extranodal NK/T-cell Lymphoma Trial in Worldwide (Tislelizumab)

      Completed
      • Peripheral T Cell Lymphoma
      • +18 more
      • Vancouver, British Columbia, Canada
      • +29 more
      Apr 29, 2022

      Solid Tumor, Haematological Malignancy, Malignant Tumor Trial in United Kingdom (Alectinib)

      Recruiting
      • Solid Tumor
      • +10 more
      • Belfast, United Kingdom
      • +25 more
      Mar 14, 2023

      Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

      Completed
      • Adult Nasal Type Extranodal NK/T-cell Lymphoma
      • +20 more
      • Scottsdale, Arizona
      • +1 more
      May 6, 2022